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To the Editor,
In healthy children adenoviral infection causes a benign, 
self-limited illness [1]. However, in immunocompromised 
patients, adenovirus can cause fulminant or disseminated 
disease such as colitis, pneumonitis, pancreatitis, nephritis, 
encephalitis, and hemophagocytic lymphohistiocytosis 
(HLH) [1,2]. Herein, we report the clinical course and 
the treatment of an infant who had no history of immune 
defects, familial HLH, or malignant disease and suffered 
from adenoviral pneumonia with progressive clinical 
deterioration due to onset of virus-associated HLH. In the 
literature there are few reports about adenovirus-associated 
HLH in healthy children. 
A previously healthy 11-month-old boy was admitted to a 
state hospital with fever and cough. His chest roentgenogram 
showed bilateral pneumonic infiltrates. The child was treated 
with ceftriaxone and amikacin but the pneumonia progressively 
worsened. Therefore, on the fifth day, his antibiotic therapy 
was changed to imipenem, amikacin, and vancomycin. The 
same day, a generalized myoclonic seizure was observed. The 
seizure was controlled by phenytoin. His liver function test 
results were elevated and the coagulation profile was deranged. 
Subsequently he was admitted to our hospital. 
On admission, he was confused. There was no response 
to verbal stimulus but he did respond to localized painful 
stimulus. His body temperature was 38.9 °C. He was tachypneic 
with retractions. Coarse crackles were audible in the right 
hemithorax, and in the left hemithorax, bronchial breathing was 
heard. The liver was enlarged 5 cm below the right subcostal 
margin. His spleen was 2 cm below the left subcostal margin. 
Complete blood count findings were as follows: 
hemoglobin, 7.1 g/dL; red blood cell distribution width, 
18.3%; mean corpuscular volume, 68 fL; mean corpuscular 
hemoglobin, 18.9 pg; mean corpuscular hemoglobin 
concentration, 321.5 g/L; leukocyte count, 4.05x109/L; 
absolute neutrophil count, 1.5x109/L; and platelet count, 
79.4x109/L. Microcytic hypochromic anemia was shown in 
the peripheral blood smear examination. His reticulocyte 
count and vitamin B12 and folate levels were normal. His 
direct Coombs test results were negative. Fibrinogen levels 
were 209 mg/dL (reference range: 200-400). Biochemical 
findings revealed aspartate aminotransferase level of 641 U/L 
(reference range: 0-40), alanine aminotransferase of 219 U/L 
(reference range: 0-41), ferritin of 1820 ng/mL (reference 
level: 20), and triglyceride of 373 mg/dL (reference range: 
35-110). Informed consent was obtained.
Chest computerized tomography demonstrated pleural 
effusion in the left hemithorax and bilateral consolidation. 
In diagnostic thoracentesis there were no visible pathologic 
findings. Serologies for chlamydial pneumonia, mycoplasma 
pneumonia, and respiratory syncytial virus were all negative. 
On the first day of admission, a localized myoclonic seizure 
was observed in his right arm. The patient required calcium-
magnesium therapy because of his low levels of serum 
calcium and magnesium. Cerebrospinal fluid test showed 
that the protein and glucose levels were in the normal range 
with no pleocytosis. 
Bone marrow aspiration revealed increased numbers 
of histiocytes and hemophagocytosis (Figure 1). The 
serum study was positive for anti-adenovirus IgM and IgG. 
Adenovirus positivity was detected in the serum at 1.3x105 
copies/mL by a very sensitive, commercially available real-
time PCR assay. These findings indicated that the patient 
had developed HLH, associated with primary adenovirus 
infection. 
Intravenous immunoglobulin (IVIG) was given for 2 
days (0.5 g/kg/day). After the second dose of IVIG therapy, 
his general condition improved. Within 3 days, fever and 
hepatosplenomegaly disappeared and transaminase levels 
returned to the normal range. Complete blood count revealed 
hemoglobin of 10.2 g/dL, leukocyte count of 8.35x109/L, 
absolute neutrophil count of 3.8x109/L, and platelet count 
of 151.2x109/L on day 21 of hospitalization. After 24 days, 
the patient was discharged without any problems. He 
is currently 27 months old and has no problems. On the 
tests done to enlighten the etiology of microcytosis, he 
was diagnosed as iron deficiency anemia. Ferrous sulphate 
therapy was started with a proper dosing. 
Although many viruses, such as the Epstein-Barr virus, 
human immunodeficiency virus, parvovirus, and hepatitis 
viruses, have been reported to cause infection-associated 
HLH, severe hemophagocytosis due to acute adenovirus 
infection is unusual [3]. There have been a limited 
number of case reports describing adenovirus pneumonia 
complicated with HLH [2,4,5,6]. In these reports, adenoviral 
pneumonia with HLH was successfully treated with IVIG and 
clarithromycin, dexamethasone and cyclosporine, or pulse 
methylprednisolone [2,4,6]. Antiviral treatment with cidofovir 
or ribavirin in adenovirus infections is being increasingly 
used, especially in immunocompromised patients; however, 
the efficacy of these drugs is not established [7,8].
We chose IVIG therapy for treatment of HLH in our 
patient. Because virus-associated HLH is rare, no certain 
treatment protocols have been described, and the role 
of IVIG in the treatment of HLH is unclear [3]. However, 
several studies have shown the beneficial effect of IVIG. 
Chen et al. [9] noted remission in only 2 of 9 children with 
virus-associated HLH treated with IVIG alone. Similarly, 
Goulder et al. [10] reported a 1-year-old boy with virus-
associated HLH successfully treated with IVIG. In our 
patient, progressive deterioration was reversed into marked 
improvement after IVIG, suggesting the therapeutic benefit 
of this treatment. 
In our patient we were able to control infection-associated 
HLH with IVIG administration. We wanted to emphasize this 
good clinical and hematologic response. In conclusion, when 
a patient suffering from adenovirus is seen with prolonged 
fever unresponsive to antibiotics, hepatosplenomegaly, and 
cytopenias, HLH should be considered in the differential 
diagnosis. 
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